MedTech News
.................... by Andrew Celentano
Slowing Aging of the Ovaries
Ovaries are one of the first organs to age, and their decline shapes women’s health decades later
Scientists uncover ‘hidden switch’ that helps cancer cells hide from the immune system
Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have uncovered a previously unknown mechanism that helps cancer cells evade detection by the body’s immune system.
Electric fields offer new hope against aggressive brain cancer
More than a decade ago, Dr. Matthew Hebb was treating patients with Parkinson’s disease using deep brain stimulation by implanting tiny electrodes into the brain and delivering electrical signals to control tremors. He wondered if the same basic technology could be used against brain cancer.
A new target in the gut for reducing Alzheimer’s risk
A compound produced by bacteria in many people’s digestive tracts increases the risk of developing Alzheimer’s disease and speeds cognitive decline in dementia patients, making it a potential target for a treatment that could reduce Alzheimer’s risk, according to a new study published in Nature Communications
FDA clears Vesalio’s latest mechanical thrombectomy device
Vesalio’s pVasc NET mechanical thrombectomy device integrates clot-capture technology to retain clot fragments during retrieval.
Freenome’s lung cancer test receives FDA breakthrough status
The SimpleScreen test is designed to detect early lung cancer signals from a standard blood sample.
FastWave Medical earns FDA IDE approval for next-gen IVL system
FastWave Medical earned FDA investigational device exemption (IDE) approval for its next-generation intravascular lithotripsy (IVL) technology, the company announced today.
Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
HENDERSON, Nev., Aug. 12, 2026 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, today announces that results utilizing its lateral flow prototype are highly correlated with results utilizing Volition’s established automated Nu.Q® NETs test in critically ill sepsis patients1 , thereby expanding beyond centralized laboratory testing.